Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

CR-000172

News Release

 View printer-friendly version

Charles River Laboratories Schedules First-Quarter 2021 Earnings Release and Conference Call

– Virtual Investor Day Scheduled on May 27th

WILMINGTON, Mass.--(BUSINESS WIRE)--Apr. 13, 2021-- Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2021 financial results on Tuesday, May 4th, before the market opens. A conference call has been scheduled to discuss this information on Tuesday, May 4th, at 9:00 a.m. ET.

Investor Day 

Charles River will also host a virtual Meeting with Management on Thursday, May 27th, starting at 8:30 a.m. ET. The virtual event will feature presentations from Charles River’s senior management team, including an overview of its strategic focus, business developments, and updated financial targets.

Investors and the general public will have the opportunity to listen to webcasts of the earnings conference call and the Investor Day event through a link that will be posted on the Investor Relations section of the Company's website at ir.criver.com. Webcast replays will be accessible through the same website.

About Charles River

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.

Investor Relations:
Todd Spencer
Corporate Vice President, Investor Relations
781.222.6455
todd.spencer@crl.com

Source: Charles River Laboratories International, Inc.

Featured Report

2020 Annual Report (PDF)

Charles River Corporate Citizenship Report
View PDF
Print PDF